6505--Cefuroxime Tablets (VA-26-00005794)
Closed Pre-Solicitation Posted
- Solicitation number
- 36E79725Q0006
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is conducting market research for the procurement of Cefuroxime Axetil Tablets through a Sources Sought Notice. This procurement will establish a national mandatory requirements contract serving multiple federal agencies including the VA, Department of Defense, Indian Health Service, Bureau of Prisons, and Federal Health Care Center. Potential contractors must meet specific requirements including possession of a unique National Drug Code, manufacturer commitment letters if not the direct manufacturer, and existing business agreements with Pharmaceutical Prime Vendors who handle distribution for VA and DoD. The contract structure envisions a base year with up to four option years to provide product continuity and consistency. Companies interested in participating must submit their responses to the market research questionnaire by August 13, 2025, with the government's objective of securing pricing below Federal Supply Schedule or open market rates.
This opportunity does not utilize any set-aside designations and is open to all qualified businesses under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The procurement encompasses four specific tablet configurations: Cefuroxime Axetil 250mg tablets in both 20 and 60-tablet bottles, and 500mg tablets in the same bottle sizes, with estimated annual usage ranging from 2,159 bottles for the lowest-demand configuration to 7,241 bottles for the highest-demand item. Successful contractors must demonstrate the ability to begin supplying products within 60 days of contract award and maintain sufficient manufacturing or distribution capacity to meet the government's committed volume requirements. The contract will block out other companies with similar products from ordering, making this an exclusive supply arrangement for the winning contractor across all participating federal agencies.
Notice text
MARKET RESEARCH QUESTIONNAIRE Cefuroxime Axetil Tablets
Company Name: _________________________
I am conducting market research for the procurement of Cefuroxime Axetil Tablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
1. Is your Company able to meet the following minimum requirements:
National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________
If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________
Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________
Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________
d. Under NAICS code 325412, is your company size (check one):
Large Business ______
Small Business ______
e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________
f. Is the offered end product U.S-made or an end product of a Trade Agreements Act designated country?_________
g. Can your company meet the following product, bottle size and usage:
ITEM
DESCRIPTION
PKG SIZE (Tablets per Bottle)
TOTAL EST ANNUAL USAGE (Bottles)
1
Cefuroxime Axetil 250mg Tablet
20
2,159
2
Cefuroxime Axetil 250mg Tablet
60
4,394
3
Cefuroxime Axetil 500mg Tablet
20
2,179
4
Cefuroxime Axetil 500mg Tablet
60
7,241
2 . Is your Company interested in submitting a response to a solicitation?________
3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________
4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date?
______________________________________________________________________
5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.
______________________________________________________________________
If you could provide your responses by August 13 , 2025, it would be greatly appreciated. Please contact me if you have any questions.
Files
| File | Type | Posted |
|---|---|---|
| 36E79725Q0006.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312) | Veterans Integrated Service Network 15 | No set-aside | |
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity